SCHEMBL13793710

SCHEMBL13793710

CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cc(Cl)c(Cl)s3)CC2)nc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 16/20 0.67
▸ ADRA2A P08913 14/20 0.67
▸ MCHR1 Q99705 14/20 0.61
▸ AQP1 P29972 2/20 0.51
▸ SLC6A4 P31645 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ NPY1R P25929 1/20 0.48
▸ NPY2R P49146 1/20 0.48
▸ NPY4R P50391 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13793737 0.91 NPY5R (0.65) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13794199 0.88 NPY5R (0.69) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13796838 0.87 NPY5R (0.68) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13793676 0.86 NPY5R (0.67) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13794079 0.85 NPY5R (0.71) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13793293 0.85 NPY5R (0.71) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13793331 0.84 NPY5R (0.73) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13794044 0.84 NPY5R (0.73) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13793758 0.84 NPY5R (0.69) NPY5RADRA2AMCHR1AQP1SLC6A4
SCHEMBL13793998 0.84 NPY5R (0.69) NPY5RADRA2AMCHR1AQP1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544690-B2 MCH receptor antagonists TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-06-09 — — US disclosed
US-7544690-B2 MCH receptor antagonists TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-06-09 — — US disclosed
Send feedback